Uronis, Hope E <br/><br/>
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.  [electronic resource] 

 -  Cancer medicine  Jun 2013 
 - 316-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-7634 
<br/><br/><label>Standard No.: </label>10.1002/cam4.65  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bevacizumab<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Oligopeptides--administration & dosage<br/>Young Adult